Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Clinical trial NCT03677960 · TERMINATED

Trial details

NCT number: NCT03677960
Sponsor: Antiva Biosciences
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

HSIL, High-Grade Squamous Intraepithelial Lesions Human Papilloma Virus Infection HIV Infection Anal Cancer Anus Neoplasm

Start date: 2018-12-17
Primary completion: 2019-06-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.